{"id":68745,"date":"2026-02-20T17:22:38","date_gmt":"2026-02-20T17:22:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68745"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"bpc-157","status":"publish","type":"product","link":"https:\/\/medsbase.com\/ja\/product\/bpc-157\/","title":{"rendered":"BPC-157"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">\u30af\u30a4\u30c3\u30af\u30a2\u30f3\u30b5\u30fc \u2014 BPC-157\u3068\u306f\uff1f<\/h3>\n<p style=\"margin: 0;\"><strong>BPC-157<\/strong> (Body Protection Compound 157) is a 15-amino-acid synthetic pentadecapeptide derived from a protective gastric protein. In published preclinical studies it has shown consistent effects on tendon, ligament, gut, muscle, and vascular tissue recovery via VEGF, nitric oxide, and growth-hormone-receptor signaling. Supplied in 2\u00a0mg to 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>MedsBase\u3067\u5f97\u3089\u308c\u308b\u3082\u306e\uff1a<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/ja\/reviews\/\">\u30ab\u30b9\u30bf\u30de\u30fc\u30ec\u30d3\u30e5\u30fc<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 \u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u5e97\u306e <a href=\"https:\/\/medsbase.com\/ja\/medsbase-re-shipment-assurance-policy\/\"><strong>\u518d\u767a\u9001\u4fdd\u8a3c\u30dd\u30ea\u30b7\u30fc<\/strong><\/a> \u2014 \u4e07\u304c\u4e00\u300120\u55b6\u696d\u65e5\u4ee5\u5185\u306b\u5546\u54c1\u304c\u5c4a\u304b\u306a\u3044\u5834\u5408\u306f\u3001\u518d\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">\u4ed5\u69d8<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">\u8a73\u7d30<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>CAS\u756a\u53f7<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">137525-51-0<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u5f0f<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub><\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5206\u5b50\u91cf<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1419.55 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u914d\u5217<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val (GEPPPGKPADDAGLV)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u5f62\u614b<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u7c89\u672b\uff08\u307e\u305f\u306f\u4f9b\u7d66\u6642\u306e\u5f62\u614b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u7d14\u5ea6<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599%\uff08HPLC\u691c\u8a3c\u6e08\u307f\u3001COA\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u63d0\u4f9b\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u4fdd\u7ba1\u65b9\u6cd5<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u51cd\u7d50\u4e7e\u71e5\u54c1\uff1a\u4f7f\u7528\u6642\u5728\u5eab\u306f2\uff5e8\u2103\uff08\u51b7\u8535\uff09\u306b\u4fdd\u7ba1\u3002\u672a\u958b\u5c01\u30d0\u30a4\u30a2\u30eb\u306e\u9577\u671f\u4fdd\u7ba1\u306b\u306f\u221220\u2103\u3002\u518d\u6eb6\u89e3\u5f8c\uff1a2\uff5e8\u2103\u3067\u7d0430\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3002\u5149\u304b\u3089\u4fdd\u8b77\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u6eb6\u89e3\u6db2\u306e\u51cd\u7d50\u878d\u89e3\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>\u6eb6\u89e3\u6027<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u9759\u83cc\u6c34\uff08\u63a8\u5968\uff09\u307e\u305f\u306f\u77ed\u6642\u9593\u4f7f\u7528\u306e\u5834\u5408\u306f\u6ec5\u83cc\u6c34<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>BPC-157\u3068\u306f\uff1f<\/h2>\n<p><strong>BPC-157<\/strong> \u306e\u7565\u79f0\u3067\u3059 <strong>\u8eab\u4f53\u4fdd\u8b77\u5316\u5408\u7269157<\/strong>, a 15-amino-acid synthetic pentadecapeptide originally isolated as a fragment of a larger protective protein found in human gastric juice. Unlike most peptides it is stable in gastric acid, which has made it a frequent subject of oral-administration studies in rodent models alongside the more common subcutaneous route. BPC-157 is one of the most widely studied healing peptides in the preclinical literature, with published work spanning tendon, ligament, gut barrier, skeletal muscle, bone, and vascular tissue. The peptide sequence is GEPPPGKPADDAGLV, molecular weight approximately 1,419\u00a0Da, empirical formula C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub>. It is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For a deep-dive on mechanism, published trial detail, and dosing considerations, see our full <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a>. <\/p>\n<h2>\u4f5c\u7528\u6a5f\u5e8f \u2014 3\u3064\u306e\u91cd\u306a\u308a\u5408\u3046\u6cbb\u7652\u7d4c\u8def<\/h2>\n<p>BPC-157\u304c\u5358\u4e00\u7d4c\u8def\u30da\u30d7\u30c1\u30c9\u3068\u7570\u306a\u308b\u306e\u306f\u3001\u305d\u306e <strong>3\u3064\u306e\u7570\u306a\u308b\u30b7\u30b0\u30ca\u30eb\u4f1d\u9054\u7d4c\u8def\u3067\u306e\u540c\u6642\u6d3b\u6027<\/strong>, each contributing to the observed tissue-recovery phenotype in published studies:<\/p>\n<ul>\n<li><strong>\u8840\u7ba1\u65b0\u751f\uff0fVEGF\u4e0a\u65b9\u5236\u5fa1<\/strong> \u2014 BPC-157\u306f\u3001\u640d\u50b7\u7d44\u7e54\u306b\u304a\u3051\u308b\u8840\u7ba1\u5185\u76ae\u5897\u6b96\u56e0\u5b50\u53d7\u5bb9\u4f532\uff08VEGFR2\uff09\u306e\u767a\u73fe\u3092\u4e0a\u65b9\u5236\u5fa1\u3057\u3001\u65b0\u305f\u306a\u6bdb\u7d30\u8840\u7ba1\u306e\u5f62\u6210\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002\u3053\u308c\u306b\u3088\u308a\u3001\u4fee\u5fa9\u90e8\u4f4d\u306e\u5c40\u6240\u704c\u6d41\u304c\u6539\u5584\u3055\u308c\u307e\u3059\u304c\u3001\u3053\u308c\u306f\u8171\u3001\u976d\u5e2f\u3001\u7b4b\u8089\u306e\u6cbb\u7652\u306b\u304a\u3051\u308b\u5f8b\u901f\u6bb5\u968e\u3067\u3059\u3002<\/li>\n<li><strong>\u4e00\u9178\u5316\u7a92\u7d20\uff08NO\uff09\u7d4c\u8def<\/strong> \u2014 BPC-157\u306f\u5185\u76ae\u578b\u4e00\u9178\u5316\u7a92\u7d20\u5408\u6210\u9175\u7d20\uff08eNOS\uff09\u306e\u6d3b\u6027\u3092\u9ad8\u3081\u3001\u8840\u7ba1\u5185\u76ae\u3092\u9178\u5316\u640d\u50b7\u304b\u3089\u4fdd\u8b77\u3057\u307e\u3059\u3002\u9580\u8108\u5727\u4ea2\u9032\u75c7\u3001\u5168\u8eab\u6027\u8840\u7ba1\u53ce\u7e2e\u3001\u80c3\u6f70\u760d\u306e\u3052\u3063\u6b6f\u985e\u30e2\u30c7\u30eb\u306b\u304a\u3044\u3066\u3001\u3053\u306e\u4f5c\u7528\u306f\u3053\u306e\u5316\u5408\u7269\u306e\u4fdd\u8b77\u4f5c\u7528\u306e\u4e2d\u5fc3\u7684\u306a\u5f79\u5272\u3092\u679c\u305f\u3057\u307e\u3059\u3002<\/li>\n<li><strong>\u6210\u9577\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\u306e\u4e0a\u65b9\u5236\u5fa1<\/strong> \u2014 BPC-157\u306f\u7dda\u7dad\u82bd\u7d30\u80de\u304a\u3088\u3073\u8171\u7d30\u80de\u4e0a\u3067\u6210\u9577\u30db\u30eb\u30e2\u30f3\u53d7\u5bb9\u4f53\uff08GHR\uff09\u306e\u767a\u73fe\u3092\u5897\u52a0\u3055\u305b\u3001I\u578b\u30b3\u30e9\u30fc\u30b2\u30f3\u306e\u5408\u6210\u3092\u4fc3\u9032\u3057\u307e\u3059\u3002\u3053\u306e\u30e1\u30ab\u30cb\u30ba\u30e0\u304c\u3001\u30a2\u30ad\u30ec\u30b9\u8171\u304a\u3088\u3073\u5185\u5074\u5074\u526f\u976d\u5e2f\u306e\u5207\u65ad\u30e2\u30c7\u30eb\u3067\u89b3\u5bdf\u3055\u308c\u305f\u8171\u306e\u5f37\u5ea6\u5411\u4e0a\u306e\u57fa\u76e4\u3067\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/li>\n<\/ul>\n<p>Because these three pathways converge on tissue that has been injured, BPC-157 produces faster and more complete recovery than single-pathway interventions in the same models. It is also notably well tolerated across the range of published doses, with minimal off-target signaling reported in toxicology studies. <\/p>\n<h2>Published Evidence<\/h2>\n<p>BPC-157 is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>\u8171\u304a\u3088\u3073\u976d\u5e2f\u640d\u50b7\u306e\u56de\u5fa9<\/strong> \u2014 \u30a2\u30ad\u30ec\u30b9\u8171\u5207\u65ad\u3001\u5185\u5074\u5074\u526f\u976d\u5e2f\u65ad\u88c2\u3001\u56de\u65cb\u7b4b\u8171\u677f\u65ad\u88c2\u306e\u3052\u3063\u6b6f\u985e\u30e2\u30c7\u30eb\uff08Chang\u3089\u3001J Appl Physiol 2011; Staresinic\u3089\u3001J Orthop Res 2003\uff09<\/li>\n<li><strong>Gut barrier integrity and ulcer studies<\/strong> \u2014 \u80c3\u6f70\u760d\u3001\u5927\u8178\u708e\u3001\u708e\u75c7\u6027\u8178\u75be\u60a3\u30e2\u30c7\u30eb\uff1bBPC-157\u304c\u80c3\u7531\u6765\u3067\u3042\u308b\u3053\u3068\u306f\u3001\u3053\u3053\u3067\u6a5f\u69cb\u7684\u306b\u95a2\u9023\u3057\u3066\u3044\u307e\u3059\uff08Sikiric\u3089\u3001Curr Med Chem 2011\uff09<\/li>\n<li><strong>\u9aa8\u683c\u7b4b\u306e\u518d\u751f<\/strong> \u2014 post-injury recovery kinetics, myoblast proliferation, and myotube formation studies<\/li>\n<li><strong>Joint and cartilage studies<\/strong> \u2014 \u5909\u5f62\u6027\u95a2\u7bc0\u75c7\u306e\u3052\u3063\u6b6f\u985e\u30e2\u30c7\u30eb\u3001\u8edf\u9aa8\u57fa\u8cea\u7d44\u6210\u3001\u6ed1\u819c\u708e\u75c7<\/li>\n<li><strong>\u8840\u7ba1\u65b0\u751f<\/strong> \u2014 \u640d\u50b7\u7d44\u7e54\u90e8\u4f4d\u3067\u306e\u65b0\u3057\u3044\u6bdb\u7d30\u8840\u7ba1\u306e\u5f62\u6210\u3068\u704c\u6d41<\/li>\n<li><strong>\u9aa8\u6cbb\u7652<\/strong> \u2014 fracture callus formation in osteotomy and bone-defect study models<\/li>\n<li><strong>Comparative recovery<\/strong> \u2014 \u7279\u306b\u4ed6\u306e\u6cbb\u7652\u30da\u30d7\u30c1\u30c9\u3068\u306e\u30d9\u30f3\u30c1\u30de\u30fc\u30af\u6bd4\u8f03 <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff09<\/a> \u5168\u8eab\u6027\u6cbb\u7652\u6bd4\u8f03\u306e\u6a19\u6e96\u7684\u306a\u5bfe\u8c61\u3068\u3057\u3066\u3002\u53c2\u7167\uff1a <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500\u6bd4\u8f03<\/a> \u5b8c\u5168\u306a\u4e26\u5217\u6bd4\u8f03\u8868\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/li>\n<\/ul>\n<p>\u6cbb\u7652\u30da\u30d7\u30c1\u30c9\u306e\u5168\u4f53\u50cf\u306b\u304a\u3051\u308bBPC-157\u306e\u4f4d\u7f6e\u3065\u3051\u306b\u3064\u3044\u3066\u306e\u3088\u308a\u5e83\u3044\u6587\u8108\u306b\u3064\u3044\u3066\u306f\u3001 <a href=\"https:\/\/medsbase.com\/ja\/best-peptides-for-muscle-recovery\/\">\u7b4b\u8089\u56de\u5fa9\u306b\u6700\u9069\u306a\u30da\u30d7\u30c1\u30c9<\/a> \u30af\u30e9\u30b9\u30bf\u30fc\u8a18\u4e8b\u3068 <a href=\"https:\/\/medsbase.com\/ja\/ghk-cu\/\">GHK-Cu \u9285\u30da\u30d7\u30c1\u30c9<\/a> as a complementary anti-aging compound. Browse the full <a href=\"https:\/\/medsbase.com\/ja\/peptides\/\">\u30da\u30d7\u30c1\u30c9\u30ab\u30bf\u30ed\u30b0<\/a> \u5316\u5408\u7269\u9078\u629e\u306e\u305f\u3081\u306b\u3002 <\/p>\n<h2>\u5229\u7528\u53ef\u80fd\u306a\u529b\u4fa1\u3068\u6fc3\u5ea6<\/h2>\n<p>MedsBase\u306f\u3001\u4ee5\u4e0b\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u30b5\u30a4\u30ba\u3067BPC-157\u3092\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\u3002\u5404\u30d0\u30ea\u30a8\u30fc\u30b7\u30e7\u30f3\u306f\u300110\u30d0\u30a4\u30a2\u30eb\u300120\u30d0\u30a4\u30a2\u30eb\u300130\u30d0\u30a4\u30a2\u30eb\u30d1\u30c3\u30af\u5f62\u5f0f\u3067\u51fa\u8377\u3055\u308c\u3001\u5b8c\u5168\u306a\u518d\u6eb6\u89e3\u30ac\u30a4\u30c0\u30f3\u30b9\u304c\u4ed8\u5c5e\u3057\u307e\u3059\uff1a<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d0\u30a4\u30a2\u30eb\u529b\u4fa1<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u4ee3\u8868\u7684\u306a\u4f7f\u7528\u4f8b<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u30d1\u30c3\u30af\u30b5\u30a4\u30ba<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>2 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Short protocols, pilot dosing, titration<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, most commonly ordered<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10\u00a0mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended protocols, lowest per-mg cost<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10\u300120\u3001\u307e\u305f\u306f30\u30d0\u30a4\u30a2\u30eb<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>All three strengths are the same chemical form (lyophilized powder, 99%+ HPLC purity). Higher-mg vials require smaller reconstitution volumes per unit dose, which is useful when users want to minimise injection volume in rodent protocols. <\/p>\n<h2>\u6bd4\u8f03 \u2014 BPC-157 vs TB-500<\/h2>\n<p>BPC-157\u3068 <a href=\"https:\/\/medsbase.com\/ja\/tb-500\/\">TB-500<\/a> are the two most-cited healing peptides. They are often studied in parallel because they act via complementary, largely non-overlapping mechanisms. Many preclinical protocols combine them rather than using either alone. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">\u8a55\u4fa1\u9805\u76ee<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">BPC-157<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">TB-500\uff08\u30b5\u30a4\u30e2\u30b7\u30f3\u30d9\u30fc\u30bf-4\uff09<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30a2\u30df\u30ce\u9178\u6570<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">15\u30a2\u30df\u30ce\u9178\uff08\u30da\u30f3\u30bf\u30c7\u30ab\u30da\u30d7\u30c1\u30c9\uff09<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">43\u30a2\u30df\u30ce\u9178\uff08\u80f8\u817a\u30da\u30d7\u30c1\u30c9\uff09<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e3b\u306a\u4f5c\u7528\u6a5f\u5e8f<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">VEGF + NO + GH\u53d7\u5bb9\u4f53\u306e\u4e0a\u65b9\u5236\u5fa1<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">G-\u30a2\u30af\u30c1\u30f3\u9694\u96e2\u3001\u7d30\u80de\u904a\u8d70<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u5206\u5e03<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u6ce8\u5c04\u90e8\u4f4d\u306b\u3088\u308a\u5c40\u6240\u7684<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5168\u8eab\u6027\u3001\u5e83\u7bc4\u56f2\u306b\u5206\u5e03<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u4e00\u822c\u7684\u306a\u7528\u91cf<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">250\uff5e500 mcg\u30011\u65e51\uff5e2\u56de<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">2\uff5e2.5 mg\u3001\u90312\u56de<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Strongest signal<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u8171\u3001\u976d\u5e2f\u3001\u8178\u7ba1\u30d0\u30ea\u30a2<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">\u5fc3\u81d3\u3001\u5168\u8eab\u306e\u7b4b\u8089\u3001\u8840\u7ba1<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>\u30b9\u30bf\u30c3\u30ad\u30f3\u30b0<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Commonly co-administered with TB-500 in studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Commonly co-administered with BPC-157 in studies<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For a full methodological comparison including dosing protocols and when users pick one over the other, read <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500: \u3042\u306a\u305f\u306e\u56de\u5fa9\u76ee\u6a19\u306b\u6700\u9069\u306a\u4fee\u5fa9\u30da\u30d7\u30c1\u30c9\u306f\u3069\u3061\u3089\u3067\u3059\u304b\uff1f<\/a>. <\/p>\n<h2>\u4fdd\u7ba1\u65b9\u6cd5\u3068\u518d\u6eb6\u89e3<\/h2>\n<p><strong>\u518d\u6eb6\u89e3\u524d\uff1a<\/strong> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u306f\u3001\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8\u2103\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u4e7e\u71e5\u72b6\u614b\u306eBPC-157\u306f\u3001\u3053\u306e\u6761\u4ef6\u4e0b\u3067\u6700\u957736\u30f6\u6708\u9593\u5b89\u5b9a\u3067\u3059\u3002\u7c89\u672b\u306e\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u907f\u3051\u3066\u304f\u3060\u3055\u3044\u3002 <strong>\u518d\u6eb6\u89e3\u624b\u9806\uff1a<\/strong> \u4e0a\u8a18\u306e\u5e0c\u91c8\u8868\u306b\u5f93\u3044\u3001\u30da\u30d7\u30c1\u30c9\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3092\u6ce8\u5165\u3057\u3066\u304f\u3060\u3055\u3044\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\u304f\u3060\u3055\u3044\uff09\u3002\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3066\u304f\u3060\u3055\u3044\u2014\u2014\u884c\u3063\u3066\u304f\u3060\u3055\u3044 <strong>\u3057\u307e\u305b\u3093<\/strong> \u632f\u3063\u3066\u2014 \u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30672\uff5e5\u5206\u9593\u9759\u7f6e\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u6b63\u3057\u304f\u518d\u69cb\u6210\u3055\u308c\u305f\u6eb6\u6db2\u306f\u900f\u660e\u3067\u7121\u8272\u3067\u306a\u3051\u308c\u3070\u306a\u308a\u307e\u305b\u3093\u3002 <strong>\u5b8c\u5168\u306b\u518d\u6eb6\u89e3\u3057\u305f\u6eb6\u6db2\u306f\u3001\u7121\u8272\u900f\u660e\u3067\u3042\u308b\u5fc5\u8981\u304c\u3042\u308a\u307e\u3059\u3002<\/strong> 2\uff5e8\u2103\u3067\u51b7\u8535\u4fdd\u5b58\u3057\u3001\u6700\u9069\u306a\u5b89\u5b9a\u6027\u3092\u5f97\u308b\u305f\u3081\u306b30\u65e5\u4ee5\u5185\u306b\u3054\u4f7f\u7528\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u2014\u2014\u51cd\u7d50\u878d\u89e3\u30b5\u30a4\u30af\u30eb\u306f\u30da\u30d7\u30c1\u30c9\u306e\u5b8c\u5168\u6027\u3092\u52a3\u5316\u3055\u305b\u307e\u3059\u3002\u6fc1\u308a\u3001\u6c88\u6bbf\u3001\u307e\u305f\u306f\u5909\u8272\u304c\u898b\u3089\u308c\u308b\u30d0\u30a4\u30a2\u30eb\u306f\u5ec3\u68c4\u3057\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h2 id=\"faqs\">\u3088\u304f\u3042\u308b\u8cea\u554f<\/h2>\n<h3>What is BPC-157 used for in studies?<\/h3>\n<p>BPC-157 is used in studies investigating tendon and ligament healing, gut barrier integrity, skeletal muscle recovery, vascular angiogenesis, anti-inflammatory signaling, and bone healing. It is <strong>\u3057\u307e\u305b\u3093<\/strong> FDA-approved and is sold here strictly for clinical studies use only. <\/p>\n<h3>BPC-157\u306fTB-500\u3068\u3069\u306e\u3088\u3046\u306b\u7570\u306a\u308a\u307e\u3059\u304b\uff1f<\/h3>\n<p>BPC-157 is a 15-amino-acid pentadecapeptide derived from gastric juice, acting mostly locally via VEGF, nitric oxide, and growth-hormone-receptor pathways. TB-500 is a 43-amino-acid thymic peptide that acts systemically via G-actin binding and cell migration. The two are often co-administered in studies because their mechanisms are complementary rather than overlapping. <\/p>\n<h3>What is the typical BPC-157 dose?<\/h3>\n<p>\u516c\u8868\u3055\u308c\u3066\u3044\u308b\u524d\u81e8\u5e8a\u30d7\u30ed\u30c8\u30b3\u30fc\u30eb\u3067\u306f\u3001\u901a\u5e381\u56de\u3042\u305f\u308a250\uff5e500mcg\u30921\u65e51\uff5e2\u56de\u30014\uff5e8\u9031\u9593\u306e\u30b5\u30a4\u30af\u30eb\u3067\u4f7f\u7528\u3057\u307e\u3059\u30025mg\u306e\u30d0\u30a4\u30a2\u30eb\u30922.0mL\u306e\u6ce8\u5c04\u7528\u9759\u83cc\u6c34\u3067\u518d\u69cb\u6210\u3059\u308b\u30682.5mg\/mL\u3068\u306a\u308a\u3001U-100\u30b7\u30ea\u30f3\u30b8\u306e10\u76ee\u76db\u308a\u304c250mcg\u306b\u76f8\u5f53\u3057\u307e\u3059\u3002 <\/p>\n<h3>BPC-157\u306fFDA\u306b\u627f\u8a8d\u3055\u308c\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>No. BPC-157 is not approved by the FDA, EMA, MHRA, or any other regulator for human therapeutic use. <\/p>\n<h3>BPC-157\u306f\u3069\u306e\u3088\u3046\u306b\u4fdd\u7ba1\u3059\u3079\u304d\u3067\u3059\u304b\uff1f<\/h3>\n<p>\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\uff1a\u5143\u306e\u5305\u88c5\u306e\u307e\u307e2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u300136\u30f6\u6708\u9593\u5b89\u5b9a\u3067\u3059\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\uff1a2\uff5e8\u00b0C\u3067\u51b7\u8535\u4fdd\u7ba1\u3057\u300130\u65e5\u4ee5\u5185\u306b\u4f7f\u7528\u3057\u3066\u304f\u3060\u3055\u3044\u3002\u518d\u69cb\u6210\u3057\u305f\u6eb6\u6db2\u306f\u51cd\u7d50\u3057\u306a\u3044\u3067\u304f\u3060\u3055\u3044\u3002\u51cd\u7d50\u878d\u89e3\u306e\u7e70\u308a\u8fd4\u3057\u306b\u3088\u308a\u30da\u30d7\u30c1\u30c9\u304c\u5206\u89e3\u3055\u308c\u307e\u3059\u3002 <\/p>\n<h3>BPC-157\u306e\u518d\u69cb\u6210\u306f\u3069\u306e\u3088\u3046\u306b\u884c\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u4e0a\u8a18\u306e\u518d\u69cb\u6210\u53c2\u7167\u30c1\u30e3\u30fc\u30c8\u306b\u5f93\u3063\u3066\u304f\u3060\u3055\u3044\u3002\u30d0\u30a4\u30a2\u30eb\u306e\u5074\u58c1\u306b\u6cbf\u3063\u3066\u9759\u83cc\u6c34\u3092\u52a0\u3048\uff08\u51cd\u7d50\u4e7e\u71e5\u30b1\u30fc\u30ad\u306b\u76f4\u63a5\u304b\u3051\u306a\u3044\u3067\uff09\u3001\u9759\u304b\u306b\u65cb\u56de\u3055\u305b\u3001\u5b8c\u5168\u306b\u6eb6\u89e3\u3059\u308b\u307e\u30672\uff5e5\u5206\u9593\u653e\u7f6e\u3057\u307e\u3059\u3002\u7d76\u5bfe\u306b <strong>\u3057\u307e\u305b\u3093<\/strong> \u30d0\u30a4\u30a2\u30eb\u3092\u632f\u3063\u3066\u304f\u3060\u3055\u3044\u3002 <\/p>\n<h3>MedsBase\u3067\u306f\u3069\u306e\u5bb9\u91cf\u306e\u30ec\u30bf\u30eb\u30c8\u30eb\u30c1\u30c9\u3092\u53d6\u308a\u63c3\u3048\u3066\u3044\u307e\u3059\u304b\uff1f<\/h3>\n<p>MedsBase\u3067\u306f\u3001BPC-157\u30922 mg\u30015 mg\u300110 mg\u306e\u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u3067\u53d6\u308a\u6271\u3063\u3066\u3044\u307e\u3059\u3002\u5404\u5bb9\u91cf\u306f10\u30d0\u30a4\u30a2\u30eb\u300120\u30d0\u30a4\u30a2\u30eb\u300130\u30d0\u30a4\u30a2\u30eb\u306e\u30d1\u30c3\u30af\u30b5\u30a4\u30ba\u3067\u3054\u5229\u7528\u3044\u305f\u3060\u3051\u307e\u3059\u3002\u3059\u3079\u3066\u306e\u30d0\u30a4\u30a2\u30eb\u306f99%\u4ee5\u4e0a\u306eHPLC\u7d14\u5ea6\u3067\u4f9b\u7d66\u3055\u308c\u3001\u5206\u6790\u8a3c\u660e\u66f8\u306f\u3054\u8981\u671b\u306b\u5fdc\u3058\u3066\u5165\u624b\u53ef\u80fd\u3067\u3059\u3002 <\/p>\n<h3>Can BPC-157 and TB-500 be stacked in studies?<\/h3>\n<p>Yes. BPC-157 and TB-500 are frequently co-administered in preclinical studies because their mechanisms are complementary. BPC-157 acts mostly locally via growth-factor upregulation; TB-500 acts systemically via G-actin binding and cell migration. Combined protocols are described in our <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-vs-tb-500-comparison-guide\/\">\u6bd4\u8f03\u30ac\u30a4\u30c9<\/a>. <\/p>\n<h3>Does BPC-157 cause side reported effects?<\/h3>\n<p>Published preclinical studies across rodent species has reported a notably clean safety profile at typical doses, with no consistent off-target signals and good tolerability. Long-term human safety data are not available because human trials have not been completed. <\/p>\n<h3>What is the difference between oral and injectable BPC-157 in studies?<\/h3>\n<p>BPC-157 is unusually stable in gastric acid due to its gastric-juice-derived origin, so oral administration is feasible in rodent protocols (unlike most peptides). Subcutaneous injection remains the most common administration route in the literature because it produces more reproducible plasma concentrations. <\/p>\n<h3>BPC-157\u306e\u534a\u6e1b\u671f\u306f\u3069\u306e\u304f\u3089\u3044\u3067\u3059\u304b\uff1f<\/h3>\n<p>In preclinical studies, BPC-157 has an estimated plasma half-life of approximately 4 hours following subcutaneous administration. Oral route studies in rodent models suggest shorter systemic clearance but sustained local effects within the gastrointestinal tract, attributed to the peptide&#8217;s unusual acid-stability. <\/p>\n<h3>How long does BPC-157 take to show effects in preclinical studies?<\/h3>\n<p>Most preclinical studies using BPC-157 in tendon, ligament, and gut injury models report measurable tissue-level changes within 7\u201314 days. The time-course varies with the study model, injury severity, route of administration, and dose used in the study design. <\/p>\n<h3>BPC-157\u3092\u56fd\u969b\u914d\u9001\u3067\u6ce8\u6587\u3067\u304d\u307e\u3059\u304b\uff1f<\/h3>\n<p>\u306f\u3044\u3002MedsBase\u3067\u306f\u3001\u5c02\u7528\u306e\u30da\u30d7\u30c1\u30c9\u767a\u9001\u30cd\u30c3\u30c8\u30ef\u30fc\u30af\u3092\u901a\u3058\u3066\u3001BPC-157\u3092\u5168\u4e16\u754c\u3078\u767a\u9001\u3044\u305f\u3057\u307e\u3059\u3002\u30da\u30d7\u30c1\u30c9\u306e\u307f\u306e\u3054\u6ce8\u6587\u306f\u3001\u5f53\u793e\u306e\u72ec\u7acb\u3057\u305f\u30da\u30d7\u30c1\u30c9\u767a\u9001\u30b5\u30fc\u30d3\u30b9\u306e\u5bfe\u8c61\u3068\u306a\u308a\u307e\u3059\u3002\u3059\u3079\u3066\u306e\u3054\u6ce8\u6587\u306f\u3001\u6e29\u5ea6\u7ba1\u7406\u3055\u308c\u305f\u5305\u88c5\u3067\u3001\u8ffd\u8de1\u756a\u53f7\u4ed8\u304d\u3067\u767a\u9001\u3055\u308c\u307e\u3059\u3002 <\/p>\n<p class=\"medsbase-bundle-link-2026-05-01\" data-marker=\"mb-bundle-link-peptide-healing-stack\">\u8171\u3001\u976d\u5e2f\u3001\u8edf\u90e8\u7d44\u7e54\u306e\u56de\u5fa9\u306e\u305f\u3081\u306eBPC-157\u30d7\u30ed\u30c8\u30b3\u30eb\u3067\u306f\u3001\u8840\u7ba1\u65b0\u751f\u304a\u3088\u3073\u7d30\u80de\u9aa8\u683c\u3078\u306e\u76f8\u4e57\u52b9\u679c\u3092\u5f97\u308b\u305f\u3081\u306b\u3001\u901a\u5e38TB-500\u3068\u4f75\u7528\u3057\u307e\u3059\u3002\u5305\u62ec\u7684\u306a\u30ec\u30b8\u30e1\u30f3\u306b\u3064\u3044\u3066\u306f\u3001\u5f53\u793e\u306e <a href=\"\/ja\/peptide-healing-stack\/\">\u30da\u30d7\u30c1\u30c9\u30d2\u30fc\u30ea\u30f3\u30b0\u30b9\u30bf\u30c3\u30af (BPC-157 5 mg + TB-500 5 mg + bacteriostatic water)<\/a> \u51cd\u7d50\u4e7e\u71e5\u30d0\u30a4\u30a2\u30eb\u3068\u518d\u69cb\u6210\u7528\u6c34\u306e\u4e21\u65b9\u30921\u3064\u306e\u5c0f\u5305\u306b\u540c\u68b1\u3057\u3001\u30da\u30d7\u30c1\u30c9\u914d\u9001\u6599$0\u3067\u3002<\/p>\n<p><!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for Recovery and Performance<\/h2>\n<ul>\n<li><a href=\"\/ja\/tb-500\/\"><strong>TB-500<\/strong><\/a> \u2014 Thymosin Beta-4 fragment \u2014 soft tissue and vascular recovery<\/li>\n<li><a href=\"\/ja\/ipamorelin\/\"><strong>Ipamorelin<\/strong><\/a> \u2014 \u9078\u629e\u7684\u30b0\u30ec\u30ea\u30f3\u4f5c\u52d5\u85ac \u2014 \u30b3\u30eb\u30c1\u30be\u30fc\u30eb\uff0f\u30d7\u30ed\u30e9\u30af\u30c1\u30f3\u3092\u4f34\u308f\u306a\u3044\u30af\u30ea\u30fc\u30f3\u306aGH\u30d1\u30eb\u30b9<\/li>\n<li><a href=\"\/ja\/cjc-1295-with-dac\/\"><strong>CJC-1295 with DAC<\/strong><\/a> \u2014 \u534a\u6e1b\u671f\u5ef6\u9577\u578bGHRH\u30a2\u30ca\u30ed\u30b0<\/li>\n<li><a href=\"\/ja\/ghk-cu\/\"><strong>GHK-Cu<\/strong><\/a> \u2014 Copper peptide \u2014 skin and connective tissue regeneration<\/li>\n<li><a href=\"\/ja\/igf-1-lr3\/\"><strong>IGF-1 LR3<\/strong><\/a> \u2014 Long-R3 IGF-1 analog \u2014 anabolic \/ regenerative support<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>\u53c2\u8003\u6587\u732e<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">\u30a8\u30d3\u30c7\u30f3\u30b9\u306b\u57fa\u3065\u304f\u5b8c\u5168\u30ac\u30a4\u30c9\u3092\u304a\u8aad\u307f\u304f\u3060\u3055\u3044\uff1a <a href=\"https:\/\/medsbase.com\/ja\/bpc-157-peptide-healing-recovery-guide\/\"><strong>BPC-157 \u2014 \u4f5c\u7528\u6a5f\u5e8f\u3001\u81e8\u5e8a\u8a66\u9a13\u30c7\u30fc\u30bf\u3001\u5c06\u6765\u306e\u5c55\u671b<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 \u7d30\u80de\u518d\u751f\u3092\u30b5\u30dd\u30fc\u30c8<br \/>\n\u2705 \u7d44\u7e54\u30ea\u30e2\u30c7\u30ea\u30f3\u30b0\u3092\u4fc3\u9032<br \/>\n\u2705 \u7dda\u7dad\u82bd\u7d30\u80de\u6d3b\u6027\u3092\u4fc3\u9032<br \/>\n\u2705 \u8840\u7ba1\u65b0\u751f\u30b7\u30b0\u30ca\u30eb\u3092\u523a\u6fc0<br \/>\n\u2705 \u7d30\u80de\u5916\u30de\u30c8\u30ea\u30c3\u30af\u30b9\u306e\u5b89\u5b9a\u6027\u3092\u5411\u4e0a<\/p>\n<p><strong>BPC-157<\/strong> \u5408\u6210\u30da\u30d7\u30c1\u30c9\u5316\u5408\u7269\u3092\u542b\u307f\u307e\u3059\u3002<\/p>","protected":false},"featured_media":70942,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5430,5441],"class_list":["post-68745","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-bpc-157-peptide","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product\/68745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/comments?post=68745"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media\/70942"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/media?parent=68745"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_brand?post=68745"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_cat?post=68745"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/ja\/wp-json\/wp\/v2\/product_tag?post=68745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}